Nanomedicine Remodels Tumor Microenvironment for Solid Tumor Immunotherapy

Area of Science:

• Immunology
• Oncology
• Nanotechnology
• Materials Science

Background:

• Immunotherapy is highly effective for hematological malignancies but shows limited efficacy against solid tumors.
• Solid tumors possess a unique immunosuppressive microenvironment characterized by chemical, cellular, and physical barriers.
• These barriers include hypoxia, acidity, pro-tumorigenic immune cell domestication, and dense physical tissue structures, all hindering immunotherapy.

Purpose of the Study:

• To highlight the critical need for reversing the immunosuppressive microenvironment in solid tumors for effective immunotherapy.
• To review recent advancements in nanomedicine-based strategies for remodeling the tumor immune microenvironment.
• To provide a comprehensive perspective on nanomedicine's role in enhancing solid tumor immunotherapy.

Main Methods:

• This perspective summarizes recent progress in nanomedicine applications for solid tumor immunotherapy.
• It focuses on how nanomedicines remodel the tumor immune microenvironment.
• The review discusses the unique properties of nanomedicines (morphology, structure, composition) that enable microenvironment modulation.

Main Results:

• Nanomedicines offer powerful tools to overcome the challenges posed by the solid tumor microenvironment.
• By remodeling immunosuppressive factors, nanomedicines can enhance immune cell activity and infiltration.
• This remodeling is crucial for improving the efficacy of immunotherapy against solid tumors.

Conclusions:

• Reversing the immunosuppressive tumor microenvironment is paramount for advancing solid tumor immunotherapy.
• Nanomedicine-based approaches are emerging as a promising strategy to achieve this goal.
• The field holds significant potential for future therapeutic developments in treating solid tumors.